CARY, N.C.--(EON: Enhanced Online News)--Biologics’ Clinical Research Services is pleased to announce the addition of frozen storage capabilities to its state-of-the-art facilities and cold-chain packaging and distribution. The new service will allow Biologics to offer a wide range of insulated shippers to distribute study materials under controlled temperature environments, and extend its already extensive clinical supply management services further into the clinical trial process.
“Our newest frozen storage and distribution offering is significant to the continued development of our Clinical Research support services”
The ability to store and ship -20C product will allow the company to be involved in pre-clinical and early phase studies where the formulations still require this temperature maintenance. To optimize the study supply, Biologics now provides protocol specific packaging design and distribution strategies. This will help take the burden of -20C storage off the study and allow trials to open to sites without this storage capability.
“Our newest frozen storage and distribution offering is significant to the continued development of our Clinical Research support services,” said Karl Buer, Business Development lead at Biologics. “We are thrilled to now support clinical trials that require frozen materials and look forward to helping drive new compounds closer to the patients who need them.”
Biologics’ Clinical Research Services team currently supports over 200 protocols across 55 active clinical trials. Licensed to dispense in all 50 states, service components include drug and supply procurement, patient kit design, inventory management and customized reporting.
About Biologics: Biologics, Inc. is an oncology services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina.